Catey Bunce spends much of his time researching Ophthalmology, Surgery, Visual acuity, Glaucoma and Intraocular pressure. Catey Bunce has included themes like Retinopathy and Prospective cohort study in his Ophthalmology study. His Surgery study combines topics in areas such as Odds ratio, Internal medicine, Combination therapy and Cornea.
His Visual acuity study combines topics from a wide range of disciplines, such as Diabetic retinopathy, Randomized controlled trial and Corneal transplantation. Many of his studies on Glaucoma involve topics that are commonly interrelated, such as Population ageing. Intraocular pressure is closely attributed to Global health in his work.
His primary areas of investigation include Ophthalmology, Surgery, Visual acuity, Glaucoma and Intraocular pressure. His studies deal with areas such as Retinopathy, Optometry and Randomized controlled trial as well as Ophthalmology. His Optometry research integrates issues from Visual impairment and Macular degeneration.
His Randomized controlled trial research also works with subjects such as
Catey Bunce mainly investigates Randomized controlled trial, Visual acuity, Ophthalmology, Glaucoma and Internal medicine. His Randomized controlled trial research is multidisciplinary, incorporating elements of Relative risk, Confidence interval and Clinical trial. His Visual acuity research entails a greater understanding of Surgery.
His work in Surgery tackles topics such as Neuro-ophthalmology which are related to areas like Retrospective cohort study. Catey Bunce focuses mostly in the field of Ophthalmology, narrowing it down to topics relating to Prospective cohort study and, in certain cases, Post-hoc analysis. Catey Bunce interconnects Treatment study and Intraocular pressure in the investigation of issues within Glaucoma.
Catey Bunce mainly focuses on Glaucoma, Randomized controlled trial, Intraocular pressure, Quality of life and Ophthalmology. His research in Randomized controlled trial intersects with topics in Absolute risk reduction, Social support and Clinical trial. His Quality of life research includes themes of Physical therapy and Visual acuity.
His Visual acuity study integrates concerns from other disciplines, such as Neuro-ophthalmology and Diabetic retinopathy. His study in Neuro-ophthalmology is interdisciplinary in nature, drawing from both Surgery and Retrospective cohort study. His research on Ophthalmology often connects related topics like Prospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2
Michel Michaelides;Michel Michaelides;Andrew Kaines;Robin D Hamilton;Samantha Fraser-Bell.
Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus.
Stephanie L. Watson;Andrew Ramsay;John K.G. Dart;Catey Bunce.
A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular Edema: 24-Month Data: Report 3
Ranjan Rajendram;Samantha Fraser-Bell;Andrew Kaines;Michel Michaelides.
Archives of Ophthalmology (2012)
The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry
PA Tonnu;T Ho;T Newson;A El Sheikh.
British Journal of Ophthalmology (2005)
A comparison of the causes of blindness certifications in England and Wales in working age adults (16–64 years), 1999–2000 with 2009–2010
Gerald Liew;Michel Michaelides;Michel Michaelides;Catey Bunce.
BMJ Open (2014)
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial
David F Garway-Heath;David P Crabb;Catey Bunce;Gerassimos Lascaratos.
The Lancet (2015)
Leading causes of certification for blindness and partial sight in England & Wales
Catey Bunce;Richard Wormald.
BMC Public Health (2006)
Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus.
Noemi Lois;Graham E. Holder;Catey Bunce;Fredrick W. Fitzke.
Archives of Ophthalmology (2001)
Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: Results from a randomized, double-blind, controlled clinical trial
Riaz Hassan Yusuf Asaria;Chee Hing Kon;Catey Bunce;David G Charteris.
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study
Adnan Tufail;Praveen J Patel;Catherine Egan;Philip Hykin.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: